| scholarly article | Q13442814 |
| P2093 | author name string | Suzanne J Baker | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 25-28 | |
| P577 | publication date | 2007-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | PTEN enters the nuclear age. | |
| P478 | volume | 128 |
| Q39816683 | (-)-Epigallocatechin-3-gallate (EGCG) increases the viability of serum-starved A549 cells through its effect on Akt. |
| Q33793019 | A High-Content Screening (HCS) Assay for the Identification of Chemical Inducers of PML Oncogenic Domains (PODs) |
| Q30417988 | A Novel PTEN/Mutant p53/c-Myc/Bcl-XL Axis Mediates Context-Dependent Oncogenic Effects of PTEN with Implications for Cancer Prognosis and Therapy |
| Q28292188 | A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival |
| Q88869540 | A chimeric protein PTEN-L-p53 enters U251 cells to repress proliferation and invasion |
| Q24606333 | A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands |
| Q47935517 | A novel PTEN mutation associated with colonic ganglioneuromatous polyps |
| Q33518037 | A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival |
| Q37097424 | Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer |
| Q24613036 | Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a |
| Q54436502 | Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation |
| Q35019216 | CREB is a novel nuclear target of PTEN phosphatase |
| Q24320241 | CSIG inhibits PTEN translation in replicative senescence |
| Q35546624 | Catalysis by the tumor-suppressor enzymes PTEN and PTEN-L. |
| Q41878469 | Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation |
| Q93116152 | Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer |
| Q33895317 | Different Conformations of Phosphatase and Tensin Homolog, Deleted on Chromosome 10 (PTEN) Protein within the Nucleus and Cytoplasm of Neurons |
| Q34151064 | Differential subcellular and extracellular localisations of proteins required for insulin-like growth factor- and extracellular matrix-induced signalling events in breast cancer progression |
| Q42737245 | Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice |
| Q37584321 | Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness |
| Q44451901 | Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway |
| Q37223890 | EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma |
| Q38275377 | Engineering PTEN function: membrane association and activity |
| Q33854076 | Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities |
| Q30487052 | Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. |
| Q91583393 | FBXO22 degrades nuclear PTEN to promote tumorigenesis |
| Q27851411 | FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. |
| Q33761221 | Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth |
| Q83641832 | Gene of the month: PTEN |
| Q36317576 | Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. |
| Q28384465 | HCV infection-associated hepatocellular carcinoma in humanized mice |
| Q53068627 | High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. |
| Q37457770 | Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene |
| Q52328367 | Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray. |
| Q39928785 | Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins. |
| Q30437740 | Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy |
| Q92859253 | Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression |
| Q42203006 | Loss of nuclear PTEN in HCV-infected human hepatocytes |
| Q35057232 | Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium |
| Q38034126 | Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents |
| Q35148037 | MiR-486 regulates lactation and targets the PTEN gene in cow mammary glands |
| Q26822717 | Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date |
| Q41611325 | NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma |
| Q35950533 | Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study |
| Q54979591 | Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility. |
| Q34986147 | Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells |
| Q38883994 | PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1. |
| Q37259680 | PTEN and the PI3-kinase pathway in cancer |
| Q42668728 | PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer |
| Q34364654 | PTEN interacts with histone H1 and controls chromatin condensation |
| Q39615345 | PTEN regulates PLK1 and controls chromosomal stability during cell division |
| Q36753139 | PTEN, more than the AKT pathway |
| Q35087328 | PTEN: Multiple Functions in Human Malignant Tumors |
| Q37270432 | PTEN: a new guardian of the genome. |
| Q33619449 | Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle |
| Q37059129 | Portrait of PTEN: messages from mutant mice. |
| Q35165208 | Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling |
| Q37094068 | Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease |
| Q37628945 | RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors |
| Q34477787 | Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. |
| Q38823123 | Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb |
| Q42003529 | Regulation of T cell homeostasis and responses by pten |
| Q35123025 | Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma |
| Q28072353 | Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies |
| Q37127301 | Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications |
| Q35064623 | SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block Reactive Oxygen Species-Induced Apoptosis in Mouse Embryonic Stem Cells |
| Q33678607 | Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth |
| Q36638098 | Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression |
| Q34229795 | The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models |
| Q24321957 | The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation |
| Q37003173 | The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway |
| Q39948774 | The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network |
| Q88955683 | The functions and regulation of the PTEN tumour suppressor: new modes and prospects |
| Q81306401 | The glycogen synthase kinase (GSK) 3beta represses RNA polymerase I transcription |
| Q37290512 | The molecular genetics of breast cancer and targeted therapy |
| Q37270446 | The role of PTEN signaling perturbations in cancer and in targeted therapy |
| Q34503492 | Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets |
| Q37270444 | Understanding PTEN regulation: PIP2, polarity and protein stability |
| Q90464875 | Up-Regulation of miR-130b-3p Activates the PTEN/PI3K/AKT/NF-κB Pathway to Defense against Mycoplasma gallisepticum (HS Strain) Infection of Chicken |
| Q49852741 | miR-21a negatively modulates tumor suppressor genes PTEN and miR-200c and further promotes the transformation of M2 macrophages |
| Q34378916 | p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN. |
Search more.